Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000320451 | SCV000369873 | benign | Maturity onset diabetes mellitus in young | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000384319 | SCV000369874 | benign | Transient Neonatal Diabetes, Dominant/Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000346143 | SCV000483259 | benign | Autosomal recessive DOPA responsive dystonia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001103213 | SCV001259939 | benign | Maturity-onset diabetes of the young type 10 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Genome- |
RCV001544276 | SCV001763285 | benign | Type 1 diabetes mellitus 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001544277 | SCV001763286 | benign | Diabetes mellitus, permanent neonatal 4 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001544278 | SCV001763287 | benign | Hyperproinsulinemia | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001103213 | SCV001763288 | benign | Maturity-onset diabetes of the young type 10 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001712011 | SCV001945011 | benign | not provided | 2019-03-31 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV003388579 | SCV004041822 | uncertain significance | Diabetes mellitus type 1 | criteria provided, single submitter | research | Potent mutations in this gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, as potent mutations in INS gene can cause beta cell destruction. rs3842753 variant, could be a contributing factor to the increased risk of T1D development, as it might increase insulin production. However more evidence are required to ascertain the role of this particular variant rs3842753 in Type 1 diabetes mellitus . | |
Breakthrough Genomics, |
RCV001712011 | SCV005321275 | benign | not provided | criteria provided, single submitter | not provided |